178 related articles for article (PubMed ID: 19917866)
1. Alpha-fetoprotein response in advanced hepatocellular carcinoma receiving cytostatic agent.
Chen LT; Shiah HS; Chao Y; Chang JY; Cheng LT; Whang-Peng J
J Clin Oncol; 2009 Dec; 27(36):e271; author reply e272. PubMed ID: 19917866
[No Abstract] [Full Text] [Related]
2. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
Giannini EG; Farinati F; Trevisani F
Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
[No Abstract] [Full Text] [Related]
3. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma.
Kilickap S; Arslan C; Senel S; Ataseven H
J Clin Oncol; 2010 Feb; 28(6):e99; author reply e100. PubMed ID: 20085931
[No Abstract] [Full Text] [Related]
4. Alpha-fetoprotein in early hepatocellular carcinoma.
Marrero JA; Feng Z
Gastroenterology; 2010 Jan; 138(1):400-1. PubMed ID: 19932214
[No Abstract] [Full Text] [Related]
5. Evaluating patients with cirrhosis for hepatocellular carcinoma: value of clinical symptomatology, imaging and alpha-fetoprotein.
Paul SB; Gulati MS; Sreenivas V; Madan K; Gupta AK; Mukhopadhyay S; Acharya SK
Oncology; 2007; 72 Suppl 1():117-23. PubMed ID: 18087192
[TBL] [Abstract][Full Text] [Related]
6. alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma.
Chen LT; Liu TW; Chao Y; Shiah HS; Chang JY; Juang SH; Chen SC; Chuang TR; Chin YH; Whang-Peng J
Aliment Pharmacol Ther; 2005 Aug; 22(3):217-26. PubMed ID: 16091059
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy of hepatocytoma--discrepancies between AFP activity and the progress of the disease].
Imaeda T; Suzuki M; Matayoshi J; Doi H
Rinsho Hoshasen; 1979; 24(2):335-6. PubMed ID: 85732
[No Abstract] [Full Text] [Related]
8. Plasma osteopontin level as a diagnostic marker of hepatocellular carcinoma in patients with radiological evidence of focal hepatic lesions.
Khalil A; Elgedawy J; Faramawi MF; Elfert A; Salama I; Abbass A; Elsaid H; Elsebaai H
Tumori; 2013; 99(1):100-7. PubMed ID: 23549008
[TBL] [Abstract][Full Text] [Related]
9. [Chronic hepatitis C presenting with a diagnosis of hepatocellular carcinoma].
Hallager S; Weis N
Ugeskr Laeger; 2014 Aug; 176(33):. PubMed ID: 25293410
[TBL] [Abstract][Full Text] [Related]
10. False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Mok TS; Yu SC; Lee C; Sung J; Leung N; Lai P; Leung TW; Chan AT; Yeo W; Koh J; Johnson P
AJR Am J Roentgenol; 2004 Aug; 183(2):453-8. PubMed ID: 15269040
[TBL] [Abstract][Full Text] [Related]
11. Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
Rahmi G; Malka D; Tomasic G; Dromain C; Ducreux M; Boige V
J Clin Oncol; 2007 Jun; 25(16):e15-6. PubMed ID: 17538153
[No Abstract] [Full Text] [Related]
12. New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Chan SL; Mo FK; Johnson PJ; Hui EP; Ma BB; Ho WM; Lam KC; Chan AT; Mok TS; Yeo W
J Clin Oncol; 2009 Jan; 27(3):446-52. PubMed ID: 19064965
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous drastic reduction of alpha-fetoprotein in hepatocellular carcinoma.
Phadke AY; Desai HG
Indian J Gastroenterol; 1996 Jul; 15(3):111. PubMed ID: 8840646
[TBL] [Abstract][Full Text] [Related]
14. History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction.
Aoyagi Y; Tamura Y; Suda T
J Gastroenterol Hepatol; 2011 Apr; 26(4):615-6. PubMed ID: 21418297
[No Abstract] [Full Text] [Related]
15. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
Trojan J; Raedle J; Zeuzem S
Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
[No Abstract] [Full Text] [Related]
16. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of hyperechoic liver tumors in MHTS.
Kimura Y; Fukada R; Katagiri S; Matsuda Y
J Med Syst; 1993 Aug; 17(3-4):127-32. PubMed ID: 7504717
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic value of alpha-fetoprotein (AFP) in hepatocellular cancer in chronic carriers of HBsAg and positive HBeAg].
Carrascosa D; Casado A; Ramírez MV; Sáez J
Aten Primaria; 1996; 18(3):147-8. PubMed ID: 8768659
[No Abstract] [Full Text] [Related]
19. Extremely High Preoperative Alpha-Fetoprotein Level Is Associated with Vascular Invasion, Non-R0 Resection, and Poor Prognosis in Hepatocellular Carcinoma Patients.
Zhang Y; Huang P; Zheng Y; Wang Y; Yuan Y; He W; Liu W; Yang Z; Wang C; Yuan Y; Li B
Am Surg; 2019 Jun; 85(6):e309-e312. PubMed ID: 31267923
[No Abstract] [Full Text] [Related]
20. [A case of hepatocellular carcinoma responding to oral administration of 5'-DFUR].
Tanaka Y; Ogino M; Tokuda H; Mizuno M; Yamauchi M
Gan To Kagaku Ryoho; 1996 Mar; 23(4):483-6. PubMed ID: 8678502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
